New drug aims to save lives from shock due to blood loss
NCT ID NCT05251181
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called centhaquine for people in hypovolemic shock, a life-threatening condition where the body doesn't have enough blood flow. About 430 adults will receive either centhaquine or a placebo along with standard care. The main goal is to see if the drug lowers the chance of death within 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOVOLEMIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.